🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud of our latest study highlighting the glucocorticoid receptor's (GR) key role in primary cancer biology, especially in determining ER-positive breast cancer subtypes and patient outcomes. Full details in the thread 🧵👇 EMBO Mol. Medicine The Netherlands Cancer Institute @UMCU_CMM embopress.org/doi/full/10.15…

UPDATED: database of 76 opportunities for early-career faculty/researchers in CANCER RESEARCH. For each opportunity, we provide description, deadline, $ amount, link, and eligibility criteria. Download this database here: research.jhu.edu/rdt/funding-op…

We are so thankful to everyone who attended and for all the speakers, Dr. Brugge, @loreleimucci, Sohrab Shah, Dr. Chang, @ScullyRalph, Jos Jonkers, Dr. Ellisen, and Sue Friedman for presenting from their various expertise! Can't wait until next year #cbrgsymposium23

#SergioRomanRoman starting the 10th Anniversary Symposium of the EurOPDX Consortium... my last duty and pleasure with #EurOPDX #friends. #farewell

📣 VHIO will be the new Chair of EurOPDX, as presented during the annual meeting celebrated in Paris, where we have discussed and presented the latest advances in Patient-Derived Models. Goretti Mallorquí has taken over as the new EurOPDX manager. Thank you, Massimiliano Borsani and

Thx ⁦⁦Cancer Grand Challenges⁩ for funding #PRECISION! Such an important project to help reduce #DCIS overtreatment. It has been an honor to serve as a Patient Advocate within an incredible team of researchers over the last six years! dcisprecision.org

On this day in 1977, Fred Sanger published the first paper demonstrating "Sanger sequencing", opening the doors to read DNA and earning him a 1980 Nobel prize. Absolutely revolutionary work🫡 The first Sanger sequencing image. Figure 1, PNAS 74:5463:5467 1977

Scientist Gian-Luca McLelland has received the Antoni van Leeuwenhoek award 2023 today. His curiosity and creativity led him to a remarkable discovery that asks for an update of the biochemistry textbooks. Read more about Gian-Luca in this interview ➡️ bit.ly/3tLApD5

Invasive lobular breast cancer is the second most common type of invasive breast cancer, but it differs from other breast cancer in some significant ways. Learn more about lobular breast cancer: ms.spr.ly/6015ifoev #lobularbreastcancer #oncology #breastcancerawareness

We’re hiring Junior Group Leader🧑‍🔬 Know anyone who might be interested?🌟 In this video, Prof Caroline Dive & Claus Jorgensen 🇪🇺🇩🇰 discuss how research at the Institute goes from lab to clinic and from clinic going back to lab. To apply: nature.com/naturecareers/…

Registration is open for #EACR2024 at #Rotterdam Great line-up of speakers! Much to learn for the next-generation 😉. Find out more here: 2024.eacr.org EACR

#AACR24 ~2,000 researchers attended this morning Pezcoller-AACR Award Lecture by Titia de Lange, on the role of telomeres and telomerase in #cancer genome instability. Dr. de Lange will come to Trento, Italy, for the Award Ceremony on May 11, open to all! pezcoller.it/en/events/pezc…

Congratulations #CancerGrandChallenges team PRECISION on their recent paper in Journal Of Pathology! Find out more 👇 @wesseling64 Jos Jonkers Van Rheenen Lab Colinda Scheele

Ecstatic and proud to share the NICHE-2 results, now published in NEJM. Out of 111 pts, 95% had an MPR , and 68% a pCR after only 4 weeks of #neoadjuvant #immunotherapy. Grateful to the pts and colleagues who made this possible. John Haanen nej.md/3Ku4X0H

Nog meer succes voor neo-adjuvante therapie: bij 95% van patiënten met een vorm van darmkanker slaat de behandeling goed aan en bij 68% is de tumor zelfs volledig verdwenen blijkt uit de resultaten van de NICHE-2 studie o.l.v. Myriam Chalabi ➡️ bit.ly/4e8rbmy

Can anyone explain to me why this paper was published in Nature? nature.com/articles/s4158…

🚨 Hormone receptor-positive #breastcancer (HR+BC) is the most common BC type, but current models fall short for #research. 🧬🔬 The latest review by Jos Jonkers team explores 6 distinct rat mammary tumor models that better mimic human HR+BC. 🐀💡 👉 link.springer.com/article/10.100…

How do endogenous #hormone fluctuations impact gene expression in the #mammarygland? Bulk RNAseq study from Renée van Amerongen team reveals: Proliferative changes during the #estrouscycle, Key gene expression shifts in adipocytes & fibroblasts, & Wnt landscape! 👉 link.springer.com/article/10.100…

Ahead of her retirement, Prof Chris Lord, Deputy Director of the Breast Cancer Now Toby Robins Research Centre at the ICR, acknowledged Baroness Delyth Morgan's role in ensuring sustained funding for the Centre's #BreastCancer research. 👇

You know you are busy when you don't even have time to tweet about the most recent paper from the lab before the journal does...